INTERFERON AND AN AGENT INDUCING INHIBITION OF PROTEIN PHOSPHATASE 2A SUCH AS INTERLEUKIN- 1 AND OPTIONALLY RIBAVIRIN FOR THE TREATMENT OF HBV OR HCV INFECTION

摘要

The present invention relates to pharmaceutical kits comprising interferons in first pharmaceutical formulation, agents inducing inhibition of Protein Phosphatase 2A (PP2A) in second pharmaceutical formulation, and further comprising ribavirin in third pharmaceutical formulation, wherein the agents inducing inhibition of PP2A are selected from the group consisting of insulin, insulin sensitizers, insulin-like growth factor-1, epidermal growth factor, tumor necrosis factor, interleukin-1, interleukin-2, interleukin-3, interleukin-5, interleukin-6, interleukin-11, interleukin-12, interleukin-13, erythropoietin, thrombopoietin, G-CSF, growth hormone, prolactin, leptin, GM-CSF, CNTF, CT-1, LIF, and OSM.